Personal information

No personal information available

Activities

Collapse all

Works (13)

A novel pharmacological entity toward integrated multimodal immunotherapy

Trends in Pharmacological Sciences
2024-12 | Journal article
DOI: 10.1016/j.tips.2024.12.001
Part of ISSN: 0165-6147
Contributors: Rafael Sirera; Manuel Beltrán-Visiedo; Lorenzo Galluzzi
Source: Self-asserted source
Manuel Beltrán-Visiedo

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors.

Cellular & molecular immunology
2024-12 | Journal article
DOI: 10.1038/s41423-024-01245-8
PMID: 39653769
Contributors: Catanzaro E; Beltrán-Visiedo M; Galluzzi L; Krysko DV
Source: Self-asserted source
Manuel Beltrán-Visiedo via Europe PubMed Central

Targeting immune evasion in hepatocellular carcinoma-initiating cells

Trends in Immunology
2024-12 | Journal article
DOI: 10.1016/j.it.2024.12.002
Part of ISSN: 1471-4906
Contributors: Rafael Sirera; Manuel Beltrán-Visiedo; Lorenzo Galluzzi
Source: Self-asserted source
Manuel Beltrán-Visiedo

Impact of radiotherapy dose, fractionation and immunotherapeutic partner in a mouse model of HR+ mammary carcinogenesis

JNCI: Journal of the National Cancer Institute
2024-12-11 | Journal article
DOI: 10.1093/jnci/djae329
Part of ISSN: 0027-8874
Part of ISSN: 1460-2105
Contributors: Aitziber Buqué; Norma Bloy; Giulia Petroni; Carlos Jiménez-Cortegana; Ai Sato; Cristina Iribarren; Takahiro Yamazaki; Claudia Galassi; Michal Hensler; Bhavneet Bhinder et al.
Source: Self-asserted source
Manuel Beltrán-Visiedo

Cytofluorometric assessment of calreticulin exposure on CD38<sup>+</sup> plasma cells from the human bone marrow.

Methods in cell biology
2024-06 | Journal article
DOI: 10.1016/bs.mcb.2024.05.009
PMID: 39393883
Contributors: Beltrán-Visiedo M; Serrano-Del Valle A; Jiménez-Aldúan N; Soler-Agesta R; Naval J; Galluzzi L; Marzo I
Source: Self-asserted source
Manuel Beltrán-Visiedo via Europe PubMed Central

Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line.

Methods in cell biology
2024-06 | Journal article
DOI: 10.1016/bs.mcb.2024.05.008
PMID: 39393881
Contributors: Campia G; Beltrán-Visiedo M; Soler-Agesta R; Sato A; Bloy N; Zhao L; Liu P; Kepp O; Kroemer G; Galluzzi L et al.
Source: Self-asserted source
Manuel Beltrán-Visiedo via Europe PubMed Central

Generation of transmitochondrial cybrids in cancer cells.

Methods in cell biology
2024-06 | Journal article
DOI: 10.1016/bs.mcb.2024.05.010
PMID: 39393884
Contributors: Soler-Agesta R; Ripollés-Yuba C; Marco-Brualla J; Moreno-Loshuertos R; Sato A; Beltrán-Visiedo M; Galluzzi L; Anel A
Source: Self-asserted source
Manuel Beltrán-Visiedo via Europe PubMed Central

MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis

Cell Research
2024-03-05 | Journal article
DOI: 10.1038/s41422-024-00939-y
Contributors: Manuel Beltrán-Visiedo; Siddharth Balachandran; Lorenzo Galluzzi
Source: check_circle
Crossref

Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients

Molecular Oncology
2023-12 | Journal article
DOI: 10.1002/1878-0261.13522
Contributors: Manuel Beltrán‐Visiedo; Nelia Jiménez‐Alduán; Rosana Díez; Marta Cuenca; Andrea Benedi; Alfonso Serrano‐Del Valle; Gemma Azaceta; Luis Palomera; Victor Peperzak; Alberto Anel et al.
Source: check_circle
Crossref

Silver‐Based Terpyridine Complexes as Antitumor Agents

Chemistry – A European Journal
2023-07-03 | Journal article
DOI: 10.1002/chem.202300116
Contributors: María Gil‐Moles; M. Elena Olmos; Miguel Monge; Manuel Beltrán‐Visiedo; Isabel Marzo; José M. López‐de‐Luzuriaga; M. Concepción Gimeno
Source: check_circle
Crossref

Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis

OncoImmunology
2022-12-31 | Journal article
DOI: 10.1080/2162402X.2022.2141973
Contributors: Alfonso Serrano Del Valle; Manuel Beltrán-Visiedo; Victoria de Poo-Rodríguez; Nelia Jiménez-Alduán; Gemma Azaceta; Rosana Díez; Beatriz Martínez-Lázaro; Isabel Izquierdo; Luis Palomera; Javier Naval et al.
Source: check_circle
Crossref

Toll-like receptors: New targets for multiple myeloma treatment?

Biochemical Pharmacology
2022-05 | Journal article
DOI: 10.1016/j.bcp.2022.114992
Part of ISSN: 0006-2952
Contributors: Manuel Beltrán-Visiedo
Source: Self-asserted source
Manuel Beltrán-Visiedo

Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids

Nanoscale
2019 | Journal article
DOI: 10.1039/c9nr06183e
Part of ISSN: 2040-3364
Part of ISSN: 2040-3372
Contributors: Manuel Beltrán-Visiedo
Source: Self-asserted source
Manuel Beltrán-Visiedo
How many people are using ORCID?